Add to ORKGThe Author(s) 2012. This article is published with open access at Springerlink.com Introduction: Tetrabenazine (TBZ) reduces chorea related to Huntington disease (HD); however, it is uncertain whether this effect improves functionally relevant motor skills such as hand coordination and balance. Th
IMPORTANCE: Deutetrabenazine is a novel molecule containing deuterium, which attenuates CYP2D6 metab...
Marissa Dean, Victor W Sung Department of Neurology, Division of Movement Disorders, University of ...
Background Although tetrabenazine, a drug that depletes presynaptic dopamine by inhibiting vesicular...
Background: Tetrabenazine is a monoamine depleter with a well-documented effect against chorea assoc...
Huntington's disease (HD) is a heredodegenerative neurological disorder with chorea and other hyperk...
OBJECTIVE: We sought to assess the short-term clinical effects of tetrabenazine (TBZ) on choreic mov...
AbstractChorea may contribute to balance problems and walking difficulties that lead to higher fall ...
Background: Tetrabenazine is a monoamine depleter with a well-documented effect against chorea assoc...
Abstract Background Tetrabenazine (TBZ) selectively depletes central monoamines by reversibly bindin...
Background: Tetrabenazine (TBZ) is commonly used in hyperkinetic movement disorders. In this retrosp...
To enhance the knowledge on the long-term efficacy and safety of tetrabenazine (TBZ) in managing cho...
Aripiprazole (AP), a dopamine (DA) D2 receptor partial agonist, has recently been used to reduce sch...
© 2017 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals, Inc. on beh...
Clinically, Huntington's disease (HD) is well known for the predominant motor symptom chorea, which ...
Background: Although tetrabenazine, a drug that depletes presynaptic dopamine by inhibiting vesicula...
IMPORTANCE: Deutetrabenazine is a novel molecule containing deuterium, which attenuates CYP2D6 metab...
Marissa Dean, Victor W Sung Department of Neurology, Division of Movement Disorders, University of ...
Background Although tetrabenazine, a drug that depletes presynaptic dopamine by inhibiting vesicular...
Background: Tetrabenazine is a monoamine depleter with a well-documented effect against chorea assoc...
Huntington's disease (HD) is a heredodegenerative neurological disorder with chorea and other hyperk...
OBJECTIVE: We sought to assess the short-term clinical effects of tetrabenazine (TBZ) on choreic mov...
AbstractChorea may contribute to balance problems and walking difficulties that lead to higher fall ...
Background: Tetrabenazine is a monoamine depleter with a well-documented effect against chorea assoc...
Abstract Background Tetrabenazine (TBZ) selectively depletes central monoamines by reversibly bindin...
Background: Tetrabenazine (TBZ) is commonly used in hyperkinetic movement disorders. In this retrosp...
To enhance the knowledge on the long-term efficacy and safety of tetrabenazine (TBZ) in managing cho...
Aripiprazole (AP), a dopamine (DA) D2 receptor partial agonist, has recently been used to reduce sch...
© 2017 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals, Inc. on beh...
Clinically, Huntington's disease (HD) is well known for the predominant motor symptom chorea, which ...
Background: Although tetrabenazine, a drug that depletes presynaptic dopamine by inhibiting vesicula...
IMPORTANCE: Deutetrabenazine is a novel molecule containing deuterium, which attenuates CYP2D6 metab...
Marissa Dean, Victor W Sung Department of Neurology, Division of Movement Disorders, University of ...
Background Although tetrabenazine, a drug that depletes presynaptic dopamine by inhibiting vesicular...